Allegro Diagnostics Closes on $5.4M
Allegro Diagnostics, a Maynard, Mass.-based developer of molecular testing platforms, has raised $5.4 million in Series A extension financing. Existing shareholders Kodiak Venture Partners and Catalyst Health Ventures participated in the round. The round will help the company support the commercialization of its lead genomic test, designed to detect early signs of lung cancer.
7 July 2011•2 mins read
